PFPG
XBIT icon

Pinnacle Financial Partners (Georgia)’s XBiotech XBIT Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Hold
11,796
– – ﹤0.01% 1126
2026
Q1 		$27.7K Hold
11,796
– – ﹤0.01% 1075
2025
Q4 		$28.2K Buy
+11,796
New +$29.1K ﹤0.01% 1045

Other funds holding XBIT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s XBIT Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) held its XBiotech (XBIT) position steady in Q2 2026 at 11,796 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

Pinnacle Financial Partners (Georgia) first reported a position in XBIT in Q4 2025 and has held it in 3 quarters since. The position peaked at $28.2K in Q4 2025. 36 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 11,796 shares of XBiotech worth $27.1K as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) left its XBiotech share count unchanged in Q2 2026.
  • XBiotech made up ﹤0.01% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #1126 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in XBiotech in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Financial Partners (Georgia)'s XBiotech position peaked at $28.2K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.